AR079312A1 - Octasulfatos de sacarosa de zinc, su preparacion y sus usos farmaceuticos y cosmeticos - Google Patents

Octasulfatos de sacarosa de zinc, su preparacion y sus usos farmaceuticos y cosmeticos

Info

Publication number
AR079312A1
AR079312A1 ARP100104511A ARP100104511A AR079312A1 AR 079312 A1 AR079312 A1 AR 079312A1 AR P100104511 A ARP100104511 A AR P100104511A AR P100104511 A ARP100104511 A AR P100104511A AR 079312 A1 AR079312 A1 AR 079312A1
Authority
AR
Argentina
Prior art keywords
pharmaceutical
zinc
octasulphates
sacarose
preparation
Prior art date
Application number
ARP100104511A
Other languages
English (en)
Spanish (es)
Original Assignee
Fabre Pierre Dermo Cosmetique
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Fabre Pierre Dermo Cosmetique filed Critical Fabre Pierre Dermo Cosmetique
Publication of AR079312A1 publication Critical patent/AR079312A1/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H11/00—Compounds containing saccharide radicals esterified by inorganic acids; Metal salts thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7016—Disaccharides, e.g. lactose, lactulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/60—Sugars; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/02—Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/10—Anti-acne agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Dermatology (AREA)
  • Epidemiology (AREA)
  • Molecular Biology (AREA)
  • Birds (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • Genetics & Genomics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Cosmetics (AREA)
  • Saccharide Compounds (AREA)
ARP100104511A 2009-12-07 2010-12-07 Octasulfatos de sacarosa de zinc, su preparacion y sus usos farmaceuticos y cosmeticos AR079312A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR0958689A FR2953522B1 (fr) 2009-12-07 2009-12-07 Sucrose octasulfates de zinc, leur preparation et leurs applications pharmaceutiques et cosmetiques

Publications (1)

Publication Number Publication Date
AR079312A1 true AR079312A1 (es) 2012-01-18

Family

ID=42044412

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP100104511A AR079312A1 (es) 2009-12-07 2010-12-07 Octasulfatos de sacarosa de zinc, su preparacion y sus usos farmaceuticos y cosmeticos

Country Status (7)

Country Link
US (1) US20120245120A1 (cg-RX-API-DMAC7.html)
EP (1) EP2509989A1 (cg-RX-API-DMAC7.html)
JP (1) JP2013512938A (cg-RX-API-DMAC7.html)
AR (1) AR079312A1 (cg-RX-API-DMAC7.html)
FR (1) FR2953522B1 (cg-RX-API-DMAC7.html)
TW (1) TW201127388A (cg-RX-API-DMAC7.html)
WO (1) WO2011069921A1 (cg-RX-API-DMAC7.html)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2977798B1 (fr) * 2011-07-13 2016-07-29 Urgo Lab Utilisation de composes oligosaccharidiques pour la prevention et le traitement des cicatrices pathologiques
FR2977797B1 (fr) * 2011-07-13 2014-01-17 Urgo Lab Utilisation cosmetique et/ou dermatologique de composes oligosaccharidiques pour la prevention et le traitement des vergetures
EP2793845A4 (en) * 2011-12-21 2016-02-24 Colgate Palmolive Co METHOD AND PRODUCTS FOR DIAGNOSIS AND TREATMENT OF OVERHEATING
FR2991876B1 (fr) 2012-06-13 2014-11-21 Vivacy Lab Composition, en milieu aqueux, comprenant au moins un acide hyaluronique et au moins un sel hydrosoluble de sucrose octasulfate
FR2993182B1 (fr) 2012-07-13 2014-10-17 Urgo Lab Pansement a liberation prolongee d'actifs
CN103193835B (zh) * 2013-04-18 2015-06-24 安徽赛诺制药有限公司 一种蔗糖八磺酸酯钠合成及纯化的方法
CN114436858A (zh) * 2020-11-03 2022-05-06 江苏开元药业有限公司 一种药用辅料的三乙胺盐的制备方法
CN116063360A (zh) * 2022-09-22 2023-05-05 麦吉丽生物科技有限公司 用于改善皮肤功能的二糖聚硫酸盐及其制备方法和用途

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR1390007A (fr) 1964-04-13 1965-02-19 Plage permettant d'intégrer sur un disque un enregistrement publicitaire ou autre
ZA869530B (en) * 1985-12-24 1987-10-28 Marion Laboratories Inc Use of synthetic sulfated saccharides to enhance wound healing
AU607690B2 (en) 1985-12-24 1991-03-14 Marion Laboratories, Inc. Use of synthetic sulfated saccharides to enhance wound healing
US5916880A (en) * 1987-12-21 1999-06-29 Bukh Meditec A/S Reduction of skin wrinkling using sulphated sugars
DK505488D0 (da) * 1987-12-21 1988-09-09 Bar Shalom Daniel Middel og anvendelse af samme
US5618798A (en) * 1989-04-20 1997-04-08 Bar-Shalom; Daniel Use of sucralfate to treat baldness
DK191889D0 (da) * 1989-04-20 1989-04-20 Bukh Meditec Kosmetisk middel
FR2646604B1 (fr) 1989-05-03 1994-02-04 Fabre Medicament Pierre Composition pour usage externe a base de sucralfate et son procede de preparation
DK86492D0 (da) 1992-06-30 1992-06-30 Bukh Meditec Laegemiddel
US20090215717A1 (en) * 2004-08-05 2009-08-27 Ivax Drug Research Institute Ltd. Sulfated oligosaccharides
FR2916355B1 (fr) * 2007-05-25 2009-08-28 Urgo Soc Par Actions Simplifie Nouveau principe actif dans la cicatrisation et son utilisation

Also Published As

Publication number Publication date
JP2013512938A (ja) 2013-04-18
FR2953522B1 (fr) 2012-03-09
US20120245120A1 (en) 2012-09-27
WO2011069921A1 (fr) 2011-06-16
WO2011069921A9 (fr) 2011-09-15
FR2953522A1 (fr) 2011-06-10
EP2509989A1 (fr) 2012-10-17
TW201127388A (en) 2011-08-16

Similar Documents

Publication Publication Date Title
AR079312A1 (es) Octasulfatos de sacarosa de zinc, su preparacion y sus usos farmaceuticos y cosmeticos
CY1121948T1 (el) Πυρρολο [1,2,f][1,2,4]tpiazineς χρησιμες για θεραπεια λοιμωξεων αναπνευστικου συγκυτιακου ιου
MX373716B (es) Compuesto de pirazol-amida y sus usos farmaceuticos.
MX2016013052A (es) Compuestos de heteroarilo o arilo biciclicos fusionados y su uso como inhibidores irak4.
MX2018008493A (es) Metodo para tratar una afeccion cutanea y composiciones de este.
MX2015015782A (es) Derivados de nucleosido 4'-fluoro-2'-metil sustituido.
AR099569A1 (es) Derivados de insulina y los usos médicos de estos
MX375274B (es) Vacuna contra la acinetobacter baumannii obtenida a partir de componentes celulares carentes de lipopolisacarido.
UA115811C2 (uk) Стабільний розчин об'єднаних баклофену, сорбіту і налтрексону для перорального застосування
PE20150167A1 (es) (r)-nifuratel, su uso para el tratamiento de las infecciones y sintesis de (r) y (s)-nifuratel
BR112015029088A2 (pt) sistema de múltiplas bateladas para preparar uma solução de hidrogeno carbonato de cálcio, e, uso de uma solução de hidrogeno carbonato de cálcio
EA201592245A1 (ru) Устройство для приготовления раствора гидрокарбоната кальция, применимого для реминерализации воды
MX2018002318A (es) Proceso mejorado para producir fucoxantina y/o polisacaridos de microalgas.
UA115373C2 (uk) Стабільний рідкий склад amg 416 (велкалсетиду)
DOP2016000064A (es) Derivados de fenilalanina sustituidos
EA201692270A1 (ru) Производные нафтиридиндиона
AR090806A1 (es) Glucosidos de pirazol y su utilizacion en el tratamiento de la diabetes tipo i y ii
PA8806501A1 (es) Triazolotriazinas y triazolopirazinas y su uso
MX2016003566A (es) Composicion que contiene polietilen glicol.
UY36064A (es) Derivados quirales de ácido ciclopentancarboxílico 2,5-disustituidos y su uso
NZ717880A (en) Glucopyranosyl-substituted indole-urea derivatives and their use as sglt inhibitors
CO6470855A2 (es) 17 beta-alquil-17alfa-oxi-esttratienos
IT201700004019A1 (it) Composizione comprendente carnitina, colato di sodio, acetato di sodio ed eventualmente argento per uso nel trattamento di psoriasi, vitiligine e rosacea
CY1117740T1 (el) Χρηση του odiparcil στη θεραπεια μιας μυκοπολυσακχαριδωσης
UY35077A (es) Formulaciones farmacéuticas y proceso de producción de formulaciones farmacéuticas

Legal Events

Date Code Title Description
FB Suspension of granting procedure